Inventor
HOLLENBACH PAUL
US3 patents
Patents
3 patentsUS10245258B2Apr 2, 2019
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
CELGENE CORP8 citations80
US10996215B2May 4, 2021
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
CELGENE CORP5 citations67
US11590117B2Feb 28, 2023
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
CELGENE CORP0 citations59